Intratumoural production of TNFα by bacteria mediates cancer therapy

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Murphy, Carola ^a   Rettedal, Elizabeth ^a   Lehouritis, Panos ^a   Devoy, Ciaran ^a,b   Tangney, Mark ^a,b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL REPLICATION; BACTERIAL SECRETION SYSTEM; BACTERIAL SPREAD; BACTERIAL SURVIVAL; BIOLUMINESCENCE; CANCER INHIBITION; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI MG1655; EX VIVO STUDY; FEMALE; GENE EXPRESSION SYSTEM; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; KIDNEY CARCINOMA; MALE; MALIGNANT NEOPLASM; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; RENAL CANCER CELL LINE; SURVIVAL ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COLORECTAL NEOPLASMS; GROWTH, DEVELOPMENT AND AGING; KIDNEY NEOPLASMS; METABOLISM; MICROBIOLOGY; PROSTATIC NEOPLASMS;

ANIMALS; COLORECTAL NEOPLASMS; ESCHERICHIA COLI; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; PROSTATIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85021680091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0180034     Document Type: Article

References (33)

1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMID: 1103152; PubMed Central PMCID: PMC433057.
2. O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, et al. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. Br J Cancer. 2000; 83(7):853-7. https://doi.org/10.1054/bjoc.2000.1401 PMID: 10970684.
3. Yuan Z, Syrkin G, Adem A, Geha R, Pastoriza J, Vrikshajanani C, et al. Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-alpha leads to synergistic antitumor activity. Cancer gene therapy. 2013; 20(1):46-56. https://doi.org/10.1038/cgt.2012.83 PMID: 23154431; PubMed Central PMCID: PMC3534156.
4. Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR, et al. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci U S A. 1992; 89 (21):10149-53. PMID: 1332031.
5. Datta R, Taneja N, Sukhatme VP, Qureshi SA, Weichselbaum R, Kufe DW. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci U S A. 1993; 90(6):2419-22. PMID: 8384722.
6. Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A. 1991; 88(6):2156-60. PMID: 1900938.
7. Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013; 31(7):886-94. https://doi.org/10.1200/JCO.2012.44.7516 PMID: 23341531; PubMed Central PMCID: PMC4820756.
8. Morrissey D, O'Sullivan GC, Tangney M. Tumour targeting with systemically administered bacteria. Current gene therapy. 2010; 10(1):3-14. PMID: 20156191.
9. Baban CK, Cronin M, O'Hanlon D, O'Sullivan GC, Tangney M. Bacteria as vectors for gene therapy of cancer. Bioeng Bugs. 2010; 1(6):385-94. Epub 2011/04/07. https://doi.org/10.4161/bbug.1.6.13146 PMID: 21468205; PubMed Central PMCID: PMC3056088.
10. van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O'Sullivan GC, et al. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther. 2010; 21 (4):405-16. Epub 2010/01/29. https://doi.org/10.1089/hum.2009.022 PMID: 20105075.
11. Lehouritis P, Springer C, Tangney M. Bacterial-directed enzyme prodrug therapy. Journal of controlled release: official journal of the Controlled Release Society. 2013; 170(1):120-31. https://doi.org/10.1016/j.jconrel.2013.05.005 PMID: 23688772.
12. Tangney M. Gene therapy for cancer: dairy bacteria as delivery vectors. Discov Med. 2010; 10 (52):195-200. Epub 2010/09/30. PMID: 20875340.
13. Cummins J, Tangney M. Bacteria and tumours: causative agents or opportunistic inhabitants? Infect Agent Cancer. 2013; 8(1):11. https://doi.org/10.1186/1750-9378-8-11 PMID: 23537317; PubMed Central PMCID: PMC3668256.
14. Feng KK, Zhao HY, Qiu H, Liu JX, Chen J. Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects. Cancer Lett. 2005; 221(1):41-7. https://doi.org/10.1016/j.canlet.2004.09.030 PMID: 15797625.
15. Agorio C, Schreiber F, Sheppard M, Mastroeni P, Fernandez M, Martinez MA, et al. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J Gene Med. 2007; 9(5):416-23. https://doi.org/10.1002/jgm.1023 PMID: 17410612.
16. Loeffler M, Le'Negrate G, Krajewska M, Reed JC. IL-18-producing Salmonella inhibit tumor growth. Cancer gene therapy. 2008; 15(12):787-94. https://doi.org/10.1038/cgt.2008.48 PMID: 18654612; PubMed Central PMCID: PMC2760299.
17. Chen J, Yang B, Cheng X, Qiao Y, Tang B, Chen G, et al. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model. Cancer science. 2012; 103 (2):325-33. https://doi.org/10.1111/j.1349-7006.2011.02147.x PMID: 22054098.
18. Loeffler M, Le'Negrate G, Krajewska M, Reed JC. Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst. 2008; 100(15):1113-6. https://doi.org/10.1093/jnci/djn205 PMID: 18664657; PubMed Central PMCID: PMC2496919.
19. Nuyts S, Van Mellaert L, Theys J, Landuyt W, Bosmans E, Anne J, et al. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther. 2001; 8(15):1197-201. https://doi.org/10.1038/sj.gt.3301499 PMID: 11509951.
20. Barbe S, Van Mellaert L, Theys J, Geukens N, Lammertyn E, Lambin P, et al. Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment. FEMS Microbiol Lett. 2005; 246(1):67-73. https://doi.org/10.1016/j.femsle.2005.03.037 PMID: 15869963.
21. Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC. Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth. Molecular therapy: The journal of the American Society of Gene Therapy. 2009; 17(6):1101-8. https://doi.org/10.1038/mt.2009.66 PMID: 19337234; PubMed Central PMCID: PMC2835175.
22. Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, Baban CK, et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PloS one. 2012; 7(1):e30940. https://doi.org/10.1371/journal.pone.0030940 PMID: 22295120; PubMed Central PMCID: PMC3266281.
23. Murphy CT, Moloney G, Macsharry J, Haynes A, Faivre E, Quinlan A, et al. Technical Advance: Function and efficacy of an {alpha}4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis. Journal of leukocyte biology. 2010; 88(6):1271-8. https://doi.org/10.1189/jlb.0909627 PMID: 20739616.
24. Theys J, Nuyts S, Landuyt W, Van Mellaert L, Dillen C, Bohringer M, et al. Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol. 1999; 65(10):4295-300. PMID: 10508051; PubMed Central PMCID: PMC91569.
25. Giacalone MJ, Gentile AM, Lovitt BT, Berkley NL, Gunderson CW, Surber MW. Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. Biotechniques. 2006; 40(3):355-64. PMID: 16568824.
26. Cronin M, Le Boeuf F, Murphy C, Roy DG, Falls T, Bell JC, et al. Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy. Molecular therapy: The journal of the American Society of Gene Therapy. 2014; 22(6):1188-97. https://doi.org/10.1038/mt.2014.23 PMID: 24569832; PubMed Central PMCID: PMC4048890.
27. Stanton M, Cronin M, Lehouritis P, Tangney M. In Vivo Bacterial Imaging without Engineering; A Novel Probe-Based Strategy Facilitated by Endogenous Nitroreductase Enzymes. Current gene therapy. 2015; 15(3):277-88. PMID: 25619884.
28. Byrne WL, Murphy CT, Cronin M, Wirth T, Tangney M. Bacterial-mediated DNA delivery to tumour associated phagocytic cells. Journal of controlled release: official journal of the Controlled Release Society. 2014; 196:384-93. https://doi.org/10.1016/j.jconrel.2014.10.030 PMID: 25466954.
29. Baban CK, Cronin M, Akin AR, O'Brien A, Gao X, Tabirca S, et al. Bioluminescent bacterial imaging in vivo. Journal of visualized experiments: JoVE. 2012;(69). https://doi.org/10.3791/4318 PMID: 23149597.
30. Cronin M, Morrissey D, Rajendran S, El Mashad SM, van Sinderen D, O'Sullivan GC, et al. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Molecular therapy: The journal of the American Society of Gene Therapy. 2010; 18(7):1397-407. https://doi.org/10.1038/mt. 2010.59 PMID: 20389288; PubMed Central PMCID: PMC2911250.
31. Flores Bueso Y, Tangney M. Synthetic Biology in the Driving Seat of the Bioeconomy. Trends in biotechnology. 2017. https://doi.org/10.1016/j.tibtech.2017.02.002 PMID: 28249675.
32. Din MO, Danino T, Prindle A, Skalak M, Selimkhanov J, Allen K, et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016; 536(7614):81-5. https://doi.org/10.1038/nature18930 PMID: 27437587; PubMed Central PMCID: PMC5048415.
33. Loessner H, Leschner S, Endmann A, Westphal K, Wolf K, Kochruebe K, et al. Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect. 2009; 11(14-15):1097-105. https://doi.org/10.1016/j.micinf.2009.08.002 PMID: 19665575.